Arakawa Keiichi, Kawai Kazushige, Ishihara Soichiro, Hata Keisuke, Nozawa Hiroaki, Oba Koji, Sugihara Kenichi, Watanabe Toshiaki
1 Department of Surgical Oncology, University of Tokyo Hospital, Tokyo, Japan 2 Department of Biostatistics, School of Public Health, Graduate School of Medicine, University of Tokyo, Tokyo, Japan 3 Department of Surgical Oncology, Tokyo Medical and Dental University, Tokyo, Japan.
Dis Colon Rectum. 2017 Oct;60(10):1041-1049. doi: 10.1097/DCR.0000000000000858.
Stage IV colorectal cancer encompasses various clinical conditions. The differences in prognosis after surgery between different metastatic organs have not been fully investigated.
This study aimed to assess prognostic significance in peritoneal metastasis in R0 resected stage IV colorectal cancer.
We conducted a multicenter retrospective study of patients with R0 resected stage IV colorectal cancer; they were categorized into 3 groups according to the number and location of metastatic organs, including single-organ metastasis in the peritoneum, single-organ metastasis at sites except the peritoneum, and multiple-organ metastases.
This study used data accumulated by the Japanese Study Group for Postoperative Follow-Up of Colorectal Cancer.
A total of 1133 patients with R0 resected stage IV colorectal cancer were registered retrospectively between 1997 and 2007 in 20 referral hospitals.
Cancer-specific survival rates between the groups were measured.
The median cancer-specific survival of the single-organ metastasis in the peritoneum group was considerably shorter than that of the single-organ metastasis at a site other than the peritoneum group and was almost comparable to that of the multiple-organ metastases group (3.41 years, 6.20 years, and 2.99 years). In a multivariate analysis of cancer-specific survival, peritoneal dissemination was confirmed as an independent prognostic factor of survival. The median postrecurrence survival of single-organ metastasis in the peritoneum group was considerably shorter than that of the single-organ metastasis at a site other than the peritoneum group. Approximately half of the patients who experienced recurrence of single-organ metastasis in the peritoneum experienced peritoneal recurrence.
This was a retrospective, population-based study that requires a prospective design to validate its conclusions.
Peritoneal metastasis of colorectal cancer frequently recurred in the peritoneum even after R0 resection. The cancer-specific survival of the single-organ metastasis in the peritoneum group was as poor as that of the multiple-organ metastases group. See Video Abstract at http://links.lww.com/DCR/A398.
IV期结直肠癌包含多种临床情况。不同转移器官术后预后的差异尚未得到充分研究。
本研究旨在评估R0切除的IV期结直肠癌腹膜转移的预后意义。
我们对R0切除的IV期结直肠癌患者进行了一项多中心回顾性研究;根据转移器官的数量和位置将他们分为3组,包括腹膜单器官转移、非腹膜部位单器官转移和多器官转移。
本研究使用了日本结直肠癌术后随访研究组积累的数据。
1997年至2007年间,20家转诊医院共回顾性登记了1133例R0切除的IV期结直肠癌患者。
测量各组之间的癌症特异性生存率。
腹膜单器官转移组的癌症特异性生存中位数明显短于非腹膜部位单器官转移组,几乎与多器官转移组相当(3.41年、6.20年和2.99年)。在癌症特异性生存的多变量分析中,腹膜播散被确认为生存的独立预后因素。腹膜单器官转移组的复发后生存中位数明显短于非腹膜部位单器官转移组。腹膜单器官转移复发的患者中约有一半发生腹膜复发。
这是一项基于人群的回顾性研究,需要前瞻性设计来验证其结论。
即使在R0切除后,结直肠癌的腹膜转移仍经常在腹膜复发。腹膜单器官转移组的癌症特异性生存与多器官转移组一样差。见视频摘要:http://links.lww.com/DCR/A398 。